miR-331-3p在恶性肿瘤中的研究进展

doi:10.11904/j.issn.1002-3070.2018.02.007

Abstract

Abstract: miRNA is a small class of endogenous non-coding RNA molecules that exist in eukaryotic cells.miR-331-3p is a member of miRNA family,which plays an important role in the physiological process.In recent years,effects of miR-331-3p on malignant tumors have been increased attention.Studies have demonstrated that miR-331-3p plays an important role in the development,recurrence and metastasis of malignant tumors such as cervical cancer,liver cancer,glioblastoma and prostate cancer.These findings contribute to help the diagnosis and prognosis of malignant tumors.

Key words: miR-331-3p, Malignant tumor, Gene expression

CLC Number:

LI Jing, ZHANG Yunyan. Research progress of miR-331-3p in malignant tumors[J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(2): 125-129.

References

1 Lund E,Guttinger S,Calado A,et al.Nuclear export of microRNA precursors[J].Science,2004,303(5654):95-98.
2 Taylor MA,Schiemann WP.Therapeutic opportunities for targeting microRNAs in cancer[J].Mol Cell Ther,2014,2(30):1-13.
3 Kojima M,Sudo H,Kawauchi J,et al.MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers[J].PLoS One,2015,10(2):e0118220.
4 Lujambio A,Lowe SW.The microcosmos of cancer[J].Nature,2012,482(7385):347-355.
5 Winter J,Jung S,Keller S,et al.Many roads to maturity:microRNA biogenesis pathways and their regulation[J].Nat Cell Biol,2009,11(3):228-234.
6 Petri A,Lindow M,Kauppinen S.MicroRNA silencing inpri-mates:towards development of novel therapeutics[J].Cancer Res,2009,69(2):393-395.
7 Epis MR,Giles KM,Barker A,et al.miR-331-3p regulates ERBB-2 expression and androgen receptor signaling in prostate cancer[J].J Biol Chem,2009,284(37):24696-24704.
8 Maes OC,Sarojini H,Wang E,et al.Stepwise up-regulation of microRNA expression levels from replicating to reversible and irreversible growth arrest states in WI-38 human fibroblasts[J].Cell Physiol,2009,221(1):109-119.
9 Guo X,Guo L,Ji J,et al.miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer[J].Biochem Biophys Res Commun,2010,398(1):1-6.
10 Zhao D,Sui Y,Zheng X.miR-331-3p inhibits proliferation and promotes apoptosis by targeting HER2 through the PI3K/Akt and ERK1/2 pathways in colorectal cancer[J].Oncol Rep,2016,35(2):1075-1082.
11 Epis MR,Barker A,Giles KM,et al.The RNA-binding protein HuR opposes the repression of ERBB-2 gene expression by microRNA miR-331-3p in prostate cancer[J].Cells,2011,286(48):41442-41454.
12 Epis MR,Giles KM,Candy PA,et al.miR-331-3p regulates expression of neuropilin-2 in glioblastoma[J].Neurooncol,2014,116(1):67-75.
13 Chang RM,Yang H,Fang F,et al.MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting pH domain and leucine-rich repeat protein phosphatase[J].Hepatology,2014,60(4):1251-1263.
14 Torre LA,Bray F,Siegel RL,et al.Global cancer statistics,2012[J].CA Cancer J Clin,2015,65(2):87-108.
15 Fujii T,Shimada K,Asano A,et al.MicroRNA-331-3p suppresses cervical cancer cell proliferation and E6/E7 expression by targeting NRP2[J].Int J Mol Sci,2016,17(8):1351.
16 Muñoz N,Castellsagué X,de González AB,et al.Chapter 1:HPV in the etiology of human cancer[J].Vaccine,2006,24(3):1-10.
17 Hausen H.Papilloma viruses causing cancer?:Evasion from host-cell control in early events in carcinogenesis[J].Natl Cancer Inst,2000,92(9):690-698.
18 Imamura Y,Sadar MD.Androgen receptor targeted therapies in castration-resistant prostate cancer:bench to clinic[J].Int J Urol,2016,23(8):654-665.
19 Bartel DP.MicroRNAs:target recognition and regulatory functions[J].Cell,2009,136(2):215-233.
20 Thieu W,Tilki D,RW deVere White R,et al.The role of microRNA in castration-resistant prostate cancer[J].Urol Oncol,2014,32(5):517-523.
21 Jung HS,Rajasekaran N,Song SY,et al.Human papillomavirus E6/E7-specific siRNA potentiates the effect of radiotherapy for cervical cancer in vitro and in vivo[J].Int J Mol Sci,2015,16(6):12243-12260.
22 White NM,Youssef YM,Fendler A,et al.The miRNA-kallikrein axis of interaction:A new dimension in the pathogenesis of prostate cancer[J].Biol Chem,2012,393(5):379-389.
23 Epis MR,Giles KM,Kalinowski FC,et al.Regulation of expression of deoxyhypusine hydroxylase(DOHH),the enzyme that catalyzes the activation of eIF5A,by miR-331-3p and miR-642-5p in prostate cancer cells[J].Biol Chem,2012,287(42):35251-35259.
24 Epis MR,Giles KM,Beveridge DJ,et al.miR-331-3p and Aurora kinase inhibitor II co-treatment suppresses prostate cancer tumorigenesis and progression[J].Oncotarget,2017,8(33):55116-55134.
25 McGlynn KA,London WT.The global epidemiology of hepatocellular carcinoma:present and future[J].Clin Liver Dis,2011,15(2):223-243.
26 Chang RM,Yang H,Fang F,et al.MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase[J].Hepatology,2014,60(4):1251-1263.
27 Cao YY,Chen J,Wang D,et al.Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells,miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5[J].Oncotarget,2015,6(35):38093-38106.
28 Xing YN,Yang X,Xu XY,et al.The altered expression of ING5 protein is involved in gastric carcinogenesis and subsequent progression[J].Hum Pathol,2011,42(1):25-35.
29 Cengiz B,Gunduz E,Gunduz M,et al.Tumor-specific mutation and downregulation of ING5 detected in oral squamous cell carcinoma[J].Int J Cancer,2010,127(9):2088-2094.
30 Coburn NG.Lymph nodes and gastric cancer[J].Surg Oncol,2009,99(4):199-206.
31 Liu XH,Sun M,Nie FQ,et al.Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer[J].Mol Cancer,2014,13(1):92.
32 Gupta RA,Shah N,Wang KC,et al.Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis[J].Nature,2010,464(7291):1071-1076.
33 Fakhari M,Pullirsch D,Abraham D,et al.Selective upregulation of vascular endothelial growth factor receptors neuropilin-1 and-2 in human neuroblastoma[J].Cancer,2002,94(1):258-263.
34 Wang L,Oberg AL,Asmann YW,et al.Genome-wide transcyiptional profiling reveals microRNA-correlated genes and biological process in human lymphoblastoid cell lines[J].PLoS One,2009,4(6):e5878.
35 De Martino I,Visone R,Fedele M,et al.Regulation of microRNA expression by HMGA1 proteins[J].Oncogene,2009,28(11):1432-1442.

[1]	ZHANG Maoxiang,SUN Huixin,SONG Bingbing. Analysis of the incidence and mortality of malignant tumors in Daoli District,Harbin,2008—2012 [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 261-265.
[2]	AI Lianjie, PIAO Daxun. Research progress in zinc finger proteins in colon cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 567-570.
[3]	HAN Bangling,WANG Yimin,XUE Yingwei. Research progress in the relationship between neutrophils and malignant tumors [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 349-352.
[4]	ZHOU Jie, CHEN Yu, CHEN Daozhen. Application of nanoparticles in photodynamic therapy of tumor [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 245-249.
[5]	HOU Siyu, CHEN Xiuwei. The structure and function of JMJD2B protein and its progress in the development of malignant tumor [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 250-253.
[6]	ZHANG Ting, HOU Guangying, WANG Xin, HE Yan. Research progress and clinical significance of QKI protein in malignant tumor [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 263-266.
[7]	JI Qiao, CHEN Li, HE Yuanqiao. Application of drug sensitivity from three-dimensional tissue in individualized precision medical treatment for tumor [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 280-284.
[8]	ZHANG Yongxin, HUANG He. Research progress and mechanism of Galectin-9 and various malignant tumors [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(2): 159-163.
[9]	WU Yifei, LIU Baogang. Research progress of thioredoxin reductase 2 in malignant tumor [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(2): 174-178.
[10]	HAN Xuejiao, LI Yanchun, SUN lichun, LU Hailing. Research progress of the relationship between 14-3-3ζ and malignant tumor [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(6): 543-547.
[11]	HAN Qian, LIN Lianjun, LIU Xinmin. Advances in gene expression profiling of metastases from unidentified primary tumor [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(6): 554-558.
[12]	HUO Mingjuan,MENG Xiangcheng,SUN Ying,CHENG Li. Research progress of ALCAM in gynecological malignant tumors [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(4): 381-384.
[13]	HAO Lixiao,ZHANG Yunyan. Research progress of AIM2 in tumor [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(2): 175-178.
[14]	FAN Mingxv, ZHAO Yanbin, LI Boyang, WANG Yan. Research progress in the Notch pathway in malignant tumors [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(1): 57-60.
[15]	WANG Jijun,HE Yan. The research progresses in USP22 in malignant tumors [J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(6): 551-554.

Research progress of miR-331-3p in malignant tumors

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments